##semicolon##
кардиология, онкология, сердечно-сосудистые заболевания, кардиотоксичность, управление рисками, кардиоонкология.##submission.citations##
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet. -2018.-392: 1736-1788
Patnaik, J.L., Byers, T., Di Guiseppi, C....Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study Breast Cancer Res.- 2011; 13, R64
Henry, M.L., Niu, J., Zhang, N....Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. // JACC Cardiovasc Imaging. 2018; 11:1084-1093
Untaru, R. Chen, D. Kelly, C....Suboptimal use of cardioprotective medications in patients with a history of cancer. //JACC Cardio Oncol.- 2020.- 2:312-315
Lancellotti, P. Suter, T.M. López-Fernández, T....Cardio-Oncology Services: rationale, organization, and implementation. //Eur Heart J. -2019; 40:1756-1763
Lyon, A.R.,Dent, S., Stanway, S....Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. //Eur J Heart Fail. -2020; 22:1945-1960
Murphy, A.C. Koshy, A.N. Farouque, O....Cardiovascular disease in patients with breast cancer treated in the modern era. //Heart Lung Circ. 2024; 33:648-656
Lyon, A.R., López-Fernández, T. Couch, L.S...., Scientific Document Group 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)// Eur Heart J. 2022; 43:4229-4361
Campia, U., Barac, A. Exercise and aerobic fitness to reduce cancer-related cardiovascular toxicity//Curr Treat Options Cardiovasc Med. 2016; 18:44
Jones L.W., Liu, Q., Armstrong, G.T....Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study//J Clin Oncol. 2014; 32:3643-3650
Scott, J.M.,Li, N. Liu, Q....Association of exercise with mortality in adult survivors of childhood cancer // JAMA Oncol. 2018; 4:13 52-1358
Herrmann, J., Lenihan, D. ∙ Armenian, S....Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. //Eur Heart J. 2021; 43:280-299
13.Lenneman, C.G., Sawyer, D.B.Cardio-Oncology: An update on cardiotoxicity of cancer-related treatment //Circ Res. 2016; 118:1008-1020
Balachandran, L., Haw, T.J. ∙ Leong, A.J.W....Cancer therapies and cardiomyocyte viability: Which drugs are directly cardiotoxic? //Heart Lung Circ. 2024; 33:747-752
Plana, J.C., Thavendiranathan, P. ∙ Bucciarelli-Ducci, C.... Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient//JACC Cardiovasc Imaging. 2018; 11:1173-1186
Zamorano, J.L., Gottfridsson, C. ∙ Asteggiano, R....The cancer patient and cardiology.// Eur J Heart Fail. 2020; 22:2290-2309
Cardinale, D., Colombo, A. ∙ Lamantia, G....Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacological therapy // J Am Coll Cardiol. 20 10; 55:213-220
Negishi, K., Negishi, T. ∙ Haluska, B.A....Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.//Eur Heart J Cardiovasc Imaging. 2013; 15:324-331
Emerson, P. Stefani, L. ∙ Boyd, A.... Alterations in left atrial strain in breast cancer patients immediately post anthracycline exposure Heart Lung Circ. 2023; 33:684-692
Nolan, M.T., Pathan, F. ∙ Nott, L... .Comparison of echocardiography and multi-planar gated acquisition scans for predicting cancer-treatment-related cardiovascular dys-function //Heart Lung Circ. 2024; 33:693-703
Tan, S., Kader, Z. ∙ Day, D.... Cardiotoxicity in oncology guidelines: discrepancies do matter//Heart Lung Circ. 2024; 33:553-557